The Photostress Recovery Test (PSRT) is an ophthalmic functional test that measures the time required for macular function to return to baseline after exposure to bright light.
The main purpose is to differentiate the cause of vision loss between macular lesions and optic neuropathy. The recovery rate after bleaching the macular photopigment with bright light reflects the function of the retinal pigment epithelium (RPE) and photoreceptors. Recovery is rapid if the RPE and photoreceptors are healthy, but delayed if they are damaged. In optic neuropathy, the structures involved in photopigment regeneration are normal, so recovery time is not prolonged (Glaser et al., 1977 PMID: 836667).
It is also useful for differentiating ocular ischemia, and recovery time is significantly prolonged even in severe carotid artery stenosis. It has been reported that after carotid endarterectomy (CEA), macular photostress recovery time shortens along with improved blood flow in the ophthalmic and retinal arteries (Geroulakos et al., 1996 PMID: 8601250).
Conditions for performing the test require a baseline best-corrected visual acuity of 20/80 (decimal visual acuity 0.25) or better. Interpretation of results is difficult with lower visual acuity.
The test requires only a standard visual acuity chart and a direct ophthalmoscope, and is positioned as a “chairside” test that does not require special equipment. Even in the modern era where imaging diagnostics such as OCT and fluorescein angiography are widely used, it retains certain clinical value as an auxiliary test to detect functional changes before structural changes occur.
The main indication is the differentiation between macular disease and optic nerve disease. It is also used to evaluate unilateral unexplained vision loss or cases where vision loss is accompanied by minimal findings (e.g., early hydroxychloroquine toxicity, asymptomatic diabetic macular edema). Additionally, it is performed preoperatively in cataract patients to assess macular function.
The criteria for interpreting recovery time are shown below.
Normal Results
Recovery time: Less than 30 seconds
Typical value in young adults: 15–25 seconds
Inter-eye difference: within a few seconds (symmetrical)
Significance: suggests causes other than macular disease (optic neuropathy, amblyopia, non-organic)
Abnormal results
Recovery time: significantly exceeds 30 seconds
>50–60 seconds: clearly abnormal
Over 90 seconds: Strongly suggests macular disease
Significance: Suggests dysfunction of the RPE or photoreceptors
Prolongation in one eye only (e.g., 45 seconds vs 20 seconds) suggests unilateral maculopathy. Bilateral prolongation suggests bilateral macular disease (e.g., advanced AMD, cone dystrophy). Recovery within normal range even in the eye with poor vision suggests non-retinal causes such as amblyopia or optic neuritis.
Macular diseases such as age-related macular degeneration (AMD), central serous chorioretinopathy, and macular dystrophy are suspected. Severe ocular ischemia due to carotid artery stenosis also causes marked prolongation (90–180 seconds or more). On the other hand, optic neuropathy and amblyopia do not prolong recovery time, making this test useful for differentiation.
The following shows a comparison of diseases and conditions that affect recovery time.
| Classification | Disease/Condition |
|---|---|
| Prolonged (macular/retinal diseases) | Age-related macular degeneration (AMD), central serous chorioretinopathy, macular dystrophy, Stargardt disease, macular edema (including diabetic), epiretinal membrane |
| Prolonged (vascular/other) | Severe carotid artery stenosis (90–180 seconds or more), aging (mild prolongation, usually less than 1 minute) |
| Does not prolong | Optic neuropathy (optic neuritis, glaucoma, compressive optic atrophy), amblyopia |
Effect of aging: Even in healthy individuals, aging slightly reduces RPE regeneration efficiency, and recovery time is slightly prolonged. However, it usually remains under 1 minute. Pupil diameter, refractive error, and baseline visual acuity do not significantly affect recovery time.
The specific protocol is shown below. As a standard method, a 10-30 second irradiation method using a direct ophthalmoscope is recommended.
The direct ophthalmoscope light is applied for a short time (10–30 seconds) without touching the eye, making it a non-invasive examination. Although afterimages and temporary glare from the strong light may occur, the intensity is safe and causes no lasting damage. The condition returns to normal within a few minutes after the examination.
The most classic use of PSRT is to differentiate whether the cause of vision loss is in the macula or the optic nerve.
It can be used to assess macular function behind cataracts. If PSRT is normal, cataract is likely the main cause of vision loss; if prolonged, concomitant macular disease is suspected. It is also useful as a screening tool before OCT.
If vision loss is present with normal fundus findings and normal PSRT, it suggests amblyopia or non-organic (psychogenic) visual impairment.
It can objectively record the subjective symptom of “difficulty recovering from glare” in patients with maculopathy. It can also be used as evidence to demonstrate the need for light-shielding measures (sunglasses, light-shielding filters) in daily life.
The physiological mechanisms underlying PSRT are described below.
Photopigment bleaching: When strong light is shone on the fovea, the photopigments in the cone cells bleach, causing a temporary decrease in visual acuity (a state of being “dazzled”).
Regeneration via the visual cycle: The bleached photopigment (all-trans retinal) is regenerated through the visual cycle in the RPE. The process is as follows:
In a healthy RPE, this visual cycle functions efficiently, enabling rapid recovery (within 30 seconds).
Prolongation in macular diseases: When the RPE or photoreceptor complex is damaged by conditions such as age-related macular degeneration or macular dystrophy, the rate of pigment regeneration decreases and recovery time is prolonged.
Normalcy in optic nerve diseases: The optic nerve is not involved in photopigment regeneration. Therefore, even in optic neuropathy, PSRT remains within the normal range. Even if baseline visual acuity is reduced, the recovery time to that baseline is not prolonged.
In the outer segment of photoreceptor cells, approximately 80 discs are newly formed each day, and the tips are shed and phagocytosed by the RPE. The Na⁺-K⁺ATPase of the RPE contributes to the formation of the dark current and also mediates water transport. The maintenance of these diverse RPE functions enables normal photopigment regeneration, and dysfunction of these processes underlies the prolongation of PSRT.
Photopigment bleaching and regeneration are carried out by the RPE and photoreceptors (cones and rods), and the optic nerve is not directly involved in this process. In optic neuropathy, even if there is damage to the conduction pathway, the visual cycle functions normally as long as the macular RPE and photoreceptors are intact, so recovery time is not prolonged.
With the widespread use of OCT and fluorescein angiography, many of the roles previously served by PSRT have been replaced by imaging. However, PSRT retains unique value in providing functional information that structural tests cannot capture.
